Aulos Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$60M
- Investors
-
2
Aulos General Information
Description
Operator of a biotechnology company intended to direct patients' immune systems toward killing tumor cells. The company's platform applies machine-learning-guided antibody design, advanced immune-pathway targeting, and precise clinical candidate development, enabling oncology researchers and clinicians focused on solid tumors to advance investigational interleukin-2-based therapies with the potential to improve immune activation and patient outcomes.
Contact Information
Website
www.aulosbio.comCorporate Office
- 700 Larkspur Landing Circle
- Suite 108
- Larkspur, CA 94939
- United States
Corporate Office
- 700 Larkspur Landing Circle
- Suite 108
- Larkspur, CA 94939
- United States
Aulos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A1) | 10-Aug-2023 | $60M | Completed | Clinical Trials - Phase 2 | ||
| 1. Early Stage VC (Series A) | 08-Jan-2021 | Completed | Clinical Trials - Phase 2 |
Aulos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aulos Comparisons
Industry
Financing
Details
Aulos Competitors (1)
One of Aulos’s competitors is Fate Therapeutics, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fate Therapeutics | Formerly VC-backed | San Diego, CA |
Aulos Patents
Aulos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260132195-A1 | Anti-il-2 antibody combinations and methods of use thereof | Pending | 04-Jan-2024 | ||
| US-20260183390-A1 | Anti-il-2 antibody combinations and methods of use thereof | Pending | 10-Nov-2022 | ||
| US-20260199460-A1 | Anti-il-2 antibody combinations and methods of use thereof | Pending | 10-Nov-2022 | ||
| US-20260207741-A1 | Anti-il-2 antibody combinations and methods of use thereof | Pending | 10-Nov-2022 | ||
| US-20260274942-A1 | Anti-il-2 antibody combinations and methods of use thereof | Pending | 10-Nov-2022 | C07K16/246 |
Aulos Signals
Aulos Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biolojic Design | VC-Backed Company | Minority | ||
| Apple Tree Partners (ATP) | Venture Capital | Minority |
Aulos FAQs
-
When was Aulos founded?
Aulos was founded in 2020.
-
Where is Aulos headquartered?
Aulos is headquartered in Larkspur, CA.
-
What is the size of Aulos?
Aulos has 9 total employees.
-
What industry is Aulos in?
Aulos’s primary industry is Drug Discovery.
-
Is Aulos a private or public company?
Aulos is a Private company.
-
What is the current valuation of Aulos?
The current valuation of Aulos is .
-
What is Aulos’s current revenue?
The current revenue for Aulos is .
-
How much funding has Aulos raised over time?
Aulos has raised $100M.
-
Who are Aulos’s investors?
Biolojic Design and Apple Tree Partners (ATP) have invested in Aulos.
-
Who are Aulos’s competitors?
Fate Therapeutics is a competitor of Aulos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process